Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors

This study has been terminated.

Study NCT00607399 Information provided by SGX Pharmaceuticals, Inc.

First Received: January 23, 2008 Last Updated: July 22, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	June 2009
Estimated Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)